Appili Therapeutics Inc.
APLIF
$0.021
-$0.0014-6.25%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.85% | 54.41% | 55.32% | 59.69% | 48.16% |
| Total Depreciation and Amortization | 12.36% | 28.00% | 65.57% | 117.02% | 43.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 68.62% | 8.46% | -30.66% | -73.33% | -36.49% |
| Change in Net Operating Assets | -15.71% | -0.42% | 246.89% | 118.95% | 108.75% |
| Cash from Operations | 80.52% | 101.58% | 92.12% | 76.36% | 76.82% |
| Capital Expenditure | 93.03% | 95.08% | 100.00% | -860.87% | -4,166.67% |
| Sale of Property, Plant, and Equipment | 119.23% | 119.23% | 117.86% | 400.00% | -196.30% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 95.56% | 97.41% | 101.84% | -881.82% | -918.18% |
| Total Debt Issued | -85.71% | -85.71% | -79.25% | -88.00% | -37.78% |
| Total Debt Repaid | -30.94% | -41.15% | -31.37% | -12.62% | 97.06% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 80.27% | 79.14% | 78.71% | -129.16% | -236.18% |
| Cash from Financing | -91.38% | -91.66% | -83.94% | -97.98% | -54.37% |
| Foreign Exchange rate Adjustments | 316.67% | -- | -103.33% | 100.00% | -101.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.47% | 112.80% | 95.62% | 45.42% | 89.89% |